- Report
- October 2024
- 200 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- January 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,253GBP
- Report
- May 2025
- 115 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- May 2025
- 154 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- July 2024
- 120 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 134 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- July 2024
- 150 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- July 2024
- 150 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- July 2024
- 150 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- May 2023
- 120 Pages
Global
From €4090EUR$4,500USD£3,527GBP
- Report
- June 2025
- 400 Pages
Global
From €4498EUR$4,949USD£3,879GBP
- Report
- June 2025
- 250 Pages
United States
From €2535EUR$2,789USD£2,186GBP
- Report
- June 2025
- 250 Pages
India
From €2535EUR$2,789USD£2,186GBP
- Report
- October 2024
- 200 Pages
Global
From €4498EUR$4,949USD£3,879GBP
- Report
- May 2024
- 106 Pages
North America
From €3136EUR$3,450USD£2,704GBP
- Report
- December 2024
- 146 Pages
Global
From €3590EUR$3,950USD£3,096GBP
From €3272EUR$3,600USD£2,822GBP
- Report
- May 2024
North America
From €1363EUR$1,500USD£1,176GBP
- Report
- May 2024
Asia Pacific
From €1363EUR$1,500USD£1,176GBP
- Report
- May 2024
Africa, Middle East
From €1363EUR$1,500USD£1,176GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more